IFBD (IFBD) Stock Price & Analysis
IFBD (IFBD) rose 4.39% to USD 1.07 as of July 25, 2026 at 03:08 UTC, according to Nexqual real-time market data.
IFBD last closed at USD 1.03; the session ranged USD 1.07–1.07 on volume of 616 shares. Market capitalization is $8.76M, with a 52-week range of USD 0.66–2.18 (NCM). Source: Nexqual, July 25, 2026 at 03:08 UTC.
Key Statistics (as of July 25, 2026 at 03:08 UTC)
| Price | USD 1.07 |
|---|---|
| Change | ▲ 4.39% (up) |
| Previous Close | USD 1.03 |
| Open | USD 1.07 |
| Day Range | USD 1.07 – 1.07 |
| 52-Week Range | USD 0.66 – 2.18 |
| Volume | 616 shares |
| Market Cap | $8.76M |
| Exchange | NCM |
Technical Analysis (IFBD)
Nexqual's technical model rates IFBD "NEUTRAL" based on 3 bullish and 2 bearish signals across 125 daily candles, as of July 25, 2026 at 03:08 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.01 (neutral) |
| vs SMA50 | Above (USD 1.03) |
| MACD | 0.01 (positive) |
Analyst Ratings (IFBD)
Wall Street analysts rate IFBD "None", per Nexqual as of July 25, 2026 at 03:08 UTC.
| Consensus Rating | None |
|---|
Earnings (IFBD)
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Financials & Fundamentals (IFBD)
| Total Revenue | $8.71M |
|---|---|
| Revenue Growth (YoY) | +271.20% |
| Gross Margin | +29.50% |
| Operating Margin | -10.50% |
| Profit Margin | +0.00% |
| ROE | -126.17% |
| Debt / Equity | 5.64 |
| Current Ratio | 1.98 |
| Total Cash | $5.11M |
| Total Debt | $1.03M |
| Free Cash Flow | $265,452 |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Financial Health Score (IFBD)
Nexqual rates IFBD's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 03:08 UTC.
| Growth | Strong — Revenue +271% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Strong — $5M cash vs $1M debt, net cash position |
| Cash Flow | Weak — Operating cash flow -$522K |
| Efficiency | Critical — ROE -126%, ROA -2.1% |
Ownership (IFBD)
| Insider Ownership | +0.02% |
|---|---|
| Institutional Ownership | +0.31% |
| Shares Outstanding | 8.19M |
| Float | 8.19M |
| Short % of Float | +0.37% |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Leadership (IFBD)
IFBD is led by Xiangyang Wen (age 38), Chairman, President & CEO, per Nexqual as of July 25, 2026 at 03:08 UTC.
| Chairman, President & CEO | Xiangyang Wen (age 38) |
|---|---|
| CFO & Director | Yiting Song (age 38) |
Major Backers & Investors (IFBD)
Notable institutional backers of IFBD include Susquehanna International Group, LLP, according to Nexqual as of July 25, 2026 at 03:08 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Susquehanna International Group, LLP | 0.3% |
Source: Nexqual, July 25, 2026 at 03:08 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AUUD | Auddia Inc. | USD 1.07 | ▼ 6.14% |
| CPOP | Pop Culture Group Co., Ltd | USD 0.38 | ▼ 5.2% |
| SNTG | Sentage Holdings Inc. | USD 2.17 | ▲ 1.88% |
| BAOS | Baosheng Media Group Holdings L | USD 1.17 | ▼ 38.1% |
| ZVSA | ZyVersa Therapeutics, Inc. | USD 0.11 | ▼ 6.78% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:08 UTC. This page is informational and not investment advice.